DaVita Inc. logo DVA - DaVita Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 9
HOLD 13
SELL 1
STRONG
SELL
0
| PRICE TARGET: $228.25 DETAILS
HIGH: $270.00
LOW: $205.00
MEDIAN: $219.00
CONSENSUS: $228.25
DOWNSIDE: 1.95%

About DaVita Inc. (https://www.davita.com)

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.

Key Executives

NAME TITLE DOB SALARY
Javier J. Rodriguez Chief Executive Officer & Executive Director 1971 $4,068,134 USD
David Maughan Chief Operating Officer of DaVita Kidney Care 1977 $1,663,804 USD
Joel Ackerman Chief Financial Officer & Treasurer 1965 $1,625,365 USD
Kathleen Alyce Waters Chief Legal & Public Affairs Officer 1968 $1,429,329 USD
James O. Hearty Chief Compliance Officer 1969 $1,071,683 USD
Christopher Michael Berry Group Vice President & Chief Accounting Officer 1975
Jeffrey Allen Giullian Chief Medical Officer of Kidney Care
Misha Palecek Chief Transformation Officer of U.S. Kidney Care Business
Nic Eliason Group Vice President of Investor Relations
Partha Das Chief Medical Officer of DaVita International
Stephanie Hendrickson Chief People Officer

Company Peers

Peer analysis pending, check back in 1-2 minutes.